All In MedTech

Device Trial Radar · NCT01645696

Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

Three-day, In-clinic, Clamp Evaluation of the BD 2nd Generation Continuous Glucose Sensor in Subjects With Type 1 Diabetes

Last checked: Nov 19, 2026Latest source record: Dec 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jun 2012

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
Becton, Dickinson and CompanyPublic (BDX)
Sponsor type
Industry
First posted
Jul 20, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Factorial
Masking
None
Primary purpose
Device feasibility
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the accuracy and performance of a new subcutaneous continuous glucose monitor (BD-CGM, Becton Dickinson) in hyperglycemic (high blood sugar) and hypoglycemic (low blood sugar) "clamp" conditions and during meal excursions over the course of 72 hours as compared to a commercially available monitor.

Conditions

  • Diabetes

Interventions

  • BD CGM with Outer LayerDevice

    continuous (every 2 minutes) subcutaneous glucose monitoring for 72 hours.

  • BD CGM without Outer LayerDevice

    continuous (every 2 minutes) subcutaneous glucose monitoring over 72 hours.

  • Medtronic iPro2 Professional CGMDevice

    continuous subcutaneous glucose monitoring for 72 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood GlucoseTime frame: 72 hours
  2. Number of participants with adverse eventsTime frame: up to 89 days or until the subject is discharged

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • >LMC Endocrinology Centre, Clinical Research Unit

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.